Specjalistyczna Praktyka Lekarska Prof. Grzegorz Opala

The Specjalistyczna Praktyka Lekarska Prof. Grzegorz Opala conducts focused investigations on disorders of the nervous system, aiming to advance therapeutic options for patients across several neurodegenerative conditions.

• Gene therapy approaches targeting neurodegeneration
• Advanced imaging biomarkers for disease activity
• Innovative delivery methods to the brain

Situated in Katowice, Poland, the site collaborates with local healthcare providers to bring cutting‑edge research to the community.

Clinical studies at the site evaluate the long‑term safety and tolerability of novel gene‑based treatments. The research focuses on Parkinson's disease and the Parkinsonian subtype of Multiple System Atrophy. These efforts aim to improve quality of life for affected individuals.

• Assessment of AB-1005 safety over extended periods
• Monitoring of motor function and disease progression
• Evaluation of surgical delivery techniques

The trials provide valuable data that may shape future standards of care for movement disorders.

Researchers are testing a new therapeutic agent, LY3541860, to determine its ability to reduce new brain lesions. The study targets adults with relapsing multiple sclerosis and seeks to offer an additional treatment option.

• Comparison of active treatment versus placebo
• Quantification of T1 Gd‑enhanced MRI lesions
• Evaluation of treatment impact on disease activity

The findings aim to inform clinicians about the potential efficacy of emerging immunomodulatory strategies.